All The Claims

1. A decorating device for decorating vehicle-interior components, of which a laser is irradiated onto the decorating surface of a resin compact or onto the decorating surface of a coat-layer formed on the resin compact to draw designs thereon that are made of the linear laser-processed part, and that the laser focal-point is shifted from the decorating surface so as to draw the designs, thus forming the gradation on a certain part of the whole design, with the decorating device being characterized in comprising a data-preparing device for preparing the drawing-data on a virtual decorating surface that is deformed so as to have a different curvature than the surface shape of the actual decorating surface, and that a laser-drawing device for forming the gradation by emitting a laser focused on the virtual decorating surface is based on the drawing-data prepared by the data-preparing device, thus conducting the laser-processing with the laser-focal point shifted from the actual decorating surface.
2. A decorating device for vehicle-interior components according to claim 1, characterized in that the laser-drawing device has functions for scanning the laser-focal point in the surface-direction on the decorating surface of the resin compact and for adjusting the focal point in the vertical-direction of the decorating surface, and that in moving the laser-focal point in the surface-direction, the laser-drawing device, based on the drawing-data, increases the focal-shift amount in the vertical-direction against the unit length in the surface-direction at the starting point of the gradation region that is connected to the provided non-gradation drawing region and gradually reduces the focal-shift amount toward the ending point of the gradation region that is away from the drawing area, thus forming the gradation on the laser-processed part of the gradation region.
3. A decorating device for vehicle-interior components according to claim 1, characterized in that the virtual-decorating surface is positioned at the side of the laser-drawing device rather than on the actual decorating surface.
4. A decorating device for vehicle-interior components according to claim 1, characterized in that the laser-drawing device draws the designs by forming the concave laser-processed part.
5. A decorating device for vehicle interior components according to claim 1, characterized in that the laser-drawing device draws the designs by forming the convex laser-processed part on the decorating surface.
6. A decorating device for vehicle interior components according to claim 1, characterized in that the laser-drawing device draws the designs by changing the color of either the coat layer surface or the component surface.
7. A decorating method for vehicle-interior components, by which a laser is irradiated onto the decorating surface of a resin compact or onto the decorating surface of a coat layer formed on the resin compact to draw thereon designs that are made within the linear laser-processed area, and that the laser focal point is shifted from the decorating surface to draw the designs, thus forming gradation on part of the whole design, characterized in that in shifting the laser focal point in the surface-direction of the decorating surface within the gradation region to provide gradation on the designs of the decorating surface, the focal-shift amount in the vertical-direction against the unit length in the surface-direction is greater at the starting point of the gradation region and gradually less toward the ending point of the gradation region, thus forming the gradation on the laser-decorating part of the gradation region.
8. A decorating method for vehicle interior components according to claim 7, characterized in that a concave laser-processed part is formed by the laser irradiation, thus drawing the design thereon.
9. A decorating method for vehicle interior components according to claim 7, characterized in that a convex laser-processed part is formed on the decorating surface by the laser irradiation, thus drawing the design thereon.
10. A decorating method for vehicle interior components according to claim 7, characterized in that the color of either the coat layer surface or the component surface is changed by the laser irradiation, thus drawing the design thereon.
11. A vehicle-interior component on which the design is drawn by using the decorating device according to claim 1 above, characterized in that the gradation is provided on the design drawn on the decorating surface with a reduction in the height or depth of the laser-processed part by a certain ratio all the way from the starting point to the ending point of the gradation region.
12. A vehicle-interior component according to claim 11, characterized in that the linear laser-processed part is formed according to the changes of the condition of the decorating surface, and the gradation is provided by a certain ratio of the reduction in the width of the laser processing part.
13. A vehicle-interior component according to claim 11, characterized in that the decorating surface is a flat surface.
14. A vehicle-interior component according to claim 11, characterized in that the decorating surface has a curved surface.

The claims below are in addition to those above.
All refrences to claim(s) which appear below refer to the numbering after this setence.

What is claimed is:

1. A compound of Formula I:
20
X is O, NCH, CR7CH or CR7N, in which R7 is hydrogen or alkyl of 1 to 6 carbon atoms;
Z is O, S or NR8, in which R8 is hydrogen or alkyl of 1 to 6 carbon atoms;
R1, R5 and R6 are, independently, hydrogen, hydroxy, halo, cyano, carboxamido, carboalkoxy of two to six carbon atoms, trifluoromethyl, alkyl of 1 to 6 carbon atoms, alkoxy of 1 to 6 carbon atoms, alkanoyl of 2 to 6 carbon atoms, alkanoyloxy of 2 to 6 carbon atoms, amino, mono- or di-alkylamino in which each alkyl group has 1 to 6 carbon atoms, alkanamido of 2 to 6 carbon atoms, alkanesulfonyl of 1 to 6 carbon atoms or alkanesulfonamido of 1 to 6 carbon atoms;
R2 is hydrogen, halo, amino, mono- or di-alkylamino in which each alkyl group has 1 to 6 carbon atoms or alkyl of 1 to 6 carbon atoms;
R3 and R4 are, independently, hydrogen or alkyl of 1 to 6 carbon atoms;
n is 1, 2 or 3;
or a pharmaceutically acceptable salt thereof.
2. A compound according to claim 1, wherein X is CR7CH where R7 is hydrogen or alkyl of 1 to 3 carbon atoms.
3. A compound according to claim 1 of Formula Ia:
21
or a pharmaceutically acceptable salt thereof.
4. A compound according to claim 1 of Formula Ib:
22
or a pharmaceutically acceptable salt thereof.
5. A compound according to claim 1, wherein R1 is hydrogen, halo, cyano, trifluoromethyl, alkyl of 1 to 6 carbon atoms or alkoxy of 1 to 6 carbon atoms.
6. A compound according to claim 1, wherein R1 is hydrogen, halo or alkoxy of 1 to 6 carbon atoms.
7. A compound according to claim 1, wherein R1 is hydrogen.
8. A compound according to claim 1, wherein R2 is hydrogen, amino or alkyl of 1 to 6 carbon atoms.
9. A compound according to claim 1, wherein R2 is hydrogen or alkyl of 1 to 3 carbon atoms.
10. A compound according to claim 1, wherein R3 and R4 are independently selected from hydrogen or alkyl of 1 to 3 carbon atoms.
11. A compound according to claim 1, wherein R4 is hydrogen.
12. A compound according to claim 1, wherein R7 and R8 are independently selected from hydrogen or alkyl of 1 to 3 carbon atoms.
13. A compound according to claim 1, wherein R5 and R6are independently selected from hydrogen, hydroxy, halo, cyano, carboxamido, alkyl of 1 to 6 carbon atoms, or alkoxy of 1 to 6 carbon atoms.
14. A compound according to claim 1, wherein R5 and R6are independently selected from hydrogen, cyano or halogen.
15. A compound according to claim 1, wherein Z is NR8 .
16. A compound according to claim 15, wherein R8 is hydrogen or alkyl of 1 to 3 carbon atoms.
17. A compound according to claim 1, wherein n is 2 or 3.
18. A compound according to claim 1, wherein R1 hydrogen, halo, cyano, trifluoromethyl, alkyl of 1 to 6 carbon atoms or alkoxy of 1 to 6 carbon atoms.
19. A compound according to claim 1, wherein R1 is hydrogen, halo or alkoxy of 1 to 6 carbon atoms, R2, R3, R7 and R8 are hydrogen or alkyl of 1 to 3 carbon atoms, R4 is hydrogen, R5 and R6 are independently hydrogen, cyano or halogen, Z is NR8 and n is 2 or 3.
20. A compound according to claim 1, wherein said compound is N-2-(5-methoxy-1H-indol-3-yl)-ethyl-N-(8-methyl-2,3-dihydro-1,4dioxino2,3-fquinolin-2-ylmethyl)-amine or a pharmaceutically acceptable salt thereof.
21. A compound according to claim 1, wherein said compound is N-2-(5-chloro-1H-indol-3-yl)ethyl-N-(8-methyl-2,3-dihydro-1,4dioxino2,3-fquinolin-2-ylmethyl)amine or a pharmaceutically acceptable salt thereof.
22. A compound according to claim 1, wherein said compound is N-3-(5-fluoro-1H-indol-3-yl)propyl-N-(8-methyl-2,3-dihydro-1,4dioxino2,3-fquinolin-2-ylmethyl)amine or a pharmaceutically acceptable salt thereof.
23. A compound according to claim 1, wherein said compound is N-2-(5-fluoro-1H-indol-3-yl)ethyl-N-(8-methyl-2,3-dihydro-1,4dioxino2,3-fquinolin-2-ylmethyl)amine or a pharmaceutically acceptable salt thereof.
24. A compound according to claim 1, wherein said compound is N-3-(5-fluoro-1H-indol-3-yl)propyl-N-(8-ethyl-2,3-dihydro-1,4dioxino2,3-fquinolin-2-ylmethyl)amine or a pharmaceutically acceptable salt thereof.
25. A compound according to claim 1, wherein said compound is N-3-(1 H-indol-3-yl)propyl-N-(8-methyl-2,3-dihydro-1,4dioxino2,3-fquinolin-2-ylmethyl)amine or a pharmaceutically acceptable salt thereof.
26. A compound according to claim 1, wherein said compound is N-3-(5-fluoro-1H-indol-3-yl)propyl-N-methyl-N-(8-methyl-2,3-dihydro-1,4dioxino2,3-fquinolin-2-ylmethyl)amine or a pharmaceutically acceptable salt thereof.
27. A compound according to claim 1, wherein said compound is N-3-(7-fluoro-1H-indol-3-yl)propyl-N-(8-methyl-2,3-dihydro-1,4dioxino2,3-fquinolin-2-ylmethyl)amine or a pharmaceutically acceptable salt thereof.
28. A compound according to claim 1, wherein said compound is N-4-(1 H-indol-3-yl)butyl-N-(8-methyl-2,3-dihydro-1,4dioxino2,3-fquinolin-2-ylmethyl)amine or a pharmaceutically acceptable salt thereof.
29. A compound according to claim 1, wherein said compound is N-4-(5-fluoro-1H-indol-3-yl)butyl-N-(8-methyl-2,3-dihydro-1,4dioxino2,3-fquinolin-2-ylmethyl)amine or a pharmaceutically acceptable salt thereof.
30. A compound according to claim 1, wherein said compound is N-4-(5-fluoro-1H-indol-3-yl)-N-(8-methyl-2,3-dihydro-1,4dioxino2,3-fquinolin-2-ylmethyl)butan-2-amine or a pharmaceutically acceptable salt thereof.
31. A compound according to claim 1, wherein said compound is N-3-(5-fluoro-1-methyl-1H-indol-3-yl)propyl-N-(8-methyl-2,3-dihydro-1,4dioxino2,3-fquinolin-2-ylmethyl)amine or a pharmaceutically acceptable salt thereof.
32. A compound according to claim 1, wherein said compound is N-3-(5,7-difluoro-1H-indol-3-yl)propyl-N-(8-methyl-2,3-dihydro-1,4dioxino2,3-fquinolin-2-ylmethyl)amine or a pharmaceutically acceptable salt thereof.
33. A compound according to claim 1, wherein said compound is N-(2,3-dihydro-1,4dioxino2,3-fquinolin-2-ylmethyl)-N-3-(5-fluoro-1H-indol-3-yl)propylamine or a pharmaceutically acceptable salt thereof.
34. A compound according to claim 1, wherein said compound is N-(2,3-dihydro-1,4dioxino2,3-fquinolin-2-ylmethyl)-N-3-(5-fluoro-1H-indol-3-yl)propyl-N-methylamine or a pharmaceutically acceptable salt thereof.
35. A compound according to claim 1, wherein said compound is N-3-(5,7-difluoro-1H-indol-3-yl)propyl-N-methyl-N-(8-methyl-2,3-dihydro-1,4dioxino2,3-fquinolin-2-ylmethyl)amine or a pharmaceutically acceptable salt thereof.
36. A compound according to claim 1, wherein said compound is N-2-(1-benzofuran-3-yl)ethyl-N-(8-methyl-2,3-dihydro-1,4dioxino2,3-fquinolin-2-ylmethyl)amine or a pharmaceutically acceptable salt thereof.
37. A compound according to claim 1, wherein said compound is N-3-(1-benzofuran-3-yl)propyl-N-(8-methyl-2,3-dihydro-1,4dioxino2,3-fquinolin-2-ylmethyl)amine or a pharmaceutically acceptable salt thereof.
38. A compound according to claim 1, wherein said compound is N-3-(7-methoxy-1-benzofuran-3-yl)propyl-N-(8-methyl-2,3-dihydro-1,4dioxino2,3-fquinolin-2-ylmethyl)amine or a pharmaceutically acceptable salt thereof.
39. A compound according to claim 1, wherein said compound is N-3-(1-benzothien-3-yl)propyl-N-(8-methyl-2,3-dihydro-1,4dioxino2,3-fquinolin-2-ylmethyl)amine or a pharmaceutically acceptable salt thereof.
40. A compound according to claim 1, wherein said compound is N-2-(1-benzothien-3-yl)ethyl-N-(8-methyl-2,3-dihydro-1,4dioxino2,3-fquinolin-2-ylmethyl)amine or a pharmaceutically acceptable salt thereof.
41. A compound according to claim 1, wherein said compound is N-3-(1-benzothien-3-yl)propyl-N-methyl-N-(8-methyl-2,3-dihydro-1,4dioxino2,3-fquinolin-2-ylmethyl)amine or a pharmaceutically acceptable salt thereof.
42. A compound according to claim 1, wherein said compound is N-3-(5-fluoro-1H-indol-3-yl)propyl-N-(2-methyl-7,8-dihydro-1,4dioxino2,3-g1,3benzoxazol-8-ylmethyl)amine or a pharmaceutically acceptable salt thereof.
43. A compound according to claim 1, wherein said compound is N-3-(5-fluoro-1H-indol-3-yl)propyl-N-methyl-N-(2-methyl-7,8-dihydro-1,4dioxino2,3-g1,3benzoxazol-8-ylmethyl)amine or a pharmaceutically acceptable salt thereof.
44. A compound according to claim 1, wherein said compound is N-ethyl-N-3-(5-Fluoro-1H-indol-3-yl)propyl-N-(8-methyl-2,3-dihydro-1,4dioxino2,3-fquinolin-2-ylmethyl)amine or a pharmaceutically acceptable salt thereof.
45. A compound according to claim 1, wherein said compound is N-3-(5,7-difluoro-1-methyl-1 H-indol-3-yl)propyl-N-(8-methyl-2,3-dihydro-1,4dioxino2,3-fquinolin-2-ylmethyl)amine or a pharmaceutically acceptable salt thereof.
46. A compound according to claim 1, wherein said compound is N-3-(5,7-difluoro-1-methyl-1 H-indol-3-yl)propyl-N-methyl-N-(8-methyl-2,3-dihydro-1,4dioxino2,3-fquinolin-2-ylmethyl)amine or a pharmaceutically acceptable salt thereof.
47. A compound according to claim 1, wherein said compound is N-4-(1-benzofuran-3-yl)butyl-N-(8-methyl-2,3-dihydro-1,4dioxino2,3-flquinolin-2-ylmethyl)amine or a pharmaceutically acceptable salt thereof.
48. A compound according to claim 1, wherein said compound is 3-3-(8-methyl-2,3-dihydro-1,4dioxino2,3-flquinolin-2-ylmethyl)-amino-propyl-1H-indole-5-carbonitrile or a pharmaceutically acceptable salt thereof.
49. A compound according to claim 1, wherein said compound is 3-3-(2-methyl-7,8-dihydro-1,4dioxino2,3-g(1,3benzoxazol-8-ylmethyl)amino-propyl-1H-indole-5-carbonitrile or a pharmaceutically acceptable salt thereof.
50. A compound according to claim 1, wherein said compound is 3-3-methyl-(2-methyl-7,8-dihydro-1,4dioxino2,3-g1,3benzoxazol-8-ylmethyl)-amino-propyl-1 H-indole-5-carbonitrile or a pharmaceutically acceptable salt thereof.
51. A compound according to claim 1, wherein said compound is 3-3-methyl-(8-methyl-2,3-dihydro-1,4dioxino2,3-fquinolin-2-ylmethyl)-amino-propyl-1H-indole-5-carbonitrile or a pharmaceutically acceptable salt thereof.
52. A compound according to claim 1, wherein said compound is 3-(6-fluoro-indol-1-yl)-propyl-(8-methyl-2,3-dihydro-1,4dioxino2,3-fquinolin-2-ylmethyl)-amine or a pharmaceutically acceptable salt thereof.
53. A compound according to claim 1, wherein said compound is 3-(6-fluoro-indol-1-yl)-propyl-methyl-(8-methyl-2,3-dihydro-1,4dioxino2,3-fquinolin-2-ylmethyl)-amine or a pharmaceutically acceptable salt thereof.
54. A compound according to claim 1, wherein said compound is 4-(5-fluoro-1 -methyl-1H-indol-3-yl)-butyl-(8-methyl-2,3-dihydro-1,4dioxino2,3-fquinolin-2-ylmethyl)-amine or a pharmaceutically acceptable salt thereof.
55. A compound according to claim 1, wherein said compound is ethyl-3-(5-fluoro-1H-indol-3-yl)-propyl-(2-methyl-7,8-dihydro-1,4dioxino2,3-g1,3benzoxazol-8-ylmethyl)-amine or a pharmaceutically acceptable salt thereof.
56. A compound according to claim 1, wherein said compound is 1-methyl-3-3-(8-methyl-2,3-dihydro-1,4dioxino2,3-fquinolin-2-ylmethyl)-amino-propyl-1H-indole-5-carbonitrile or a pharmaceutically acceptable slat thereof.
57. A compound according to claim 1, wherein said compound is 4-(6-fluoro-indol-1-yl)-butyl-(8-methyl-2,3-dihydro-1,4dioxino2,3-fquinolin-2-ylmethyl)-amine or a pharmaceutically acceptable salt thereof.
58. A compound according to claim 1, wherein said compound is 3-4-(8-methyl-2,3-dihydro-1,4dioxino2,3-fquinolin-2-ylmethyl)-amino-butyl-1 H-indole-5-carbonitrile or a pharmaceutically acceptable salt thereof.
59. A compound according to claim 1, wherein said compound is 1-methyl-3-3-methyl-(8-methyl-2,3-dihydro-1,4dioxino2,3-fquinolin-2-ylmethyl)-amino-propyl-1H-indole-5-carbonitrile or a pharmaceutically acceptable salt thereof.
60. A compound according to claim 1, wherein said compound is 3-4-methyl-(8-methyl-2,3-dihydro-1,4dioxino2,3-fquinolin-2-ylmethyl)-amino-butyl-1H-indole-5-carbonitrile or a pharmaceutically acceptable salt thereof.
61. A compound according to claim 1, wherein said compound is 3-(5-fluoro-1-methyl-1H-indol-3-yl)-propyl-methyl-(8-methyl-2,3-dihydro-1,4dioxino2,3-fquinolin-2-ylmethyl)-amine or a pharmaceutically acceptable salt thereof.
62. A compound according to claim 1, wherein said compound is 4-(5-fluoro-1H-indol-3-yl)-butyl-methyl-(8-methyl-2,3-dihydro-1,4dioxino2,3-fquinolin-2-ylmethyl)-amine or a pharmaceutically acceptable salt thereof.
63. A compound according to claim 1, wherein said compound is 4-(5-fluoro-1-methyl-1H-indol-3-yl)-butyl-methyl-(8-methyl-2,3-dihydro-1,4dioxino2,3-fquinolin-2-ylmethyl)-amine or a pharmaceutically acceptable salt thereof.
64. A compound according to claim 1, wherein said compound is (3-(5-fluoro-1H-indol-3-yl)-propyl-(8-methyl-2,3-dihydro-1,4dioxino2,3-fquinolin-2-ylmethyl)-propyl-amine or a pharmaceutically acceptable salt thereof.
65. A compound according to claim 1, wherein said compound is 3-(4-fluoro-indol-1-yl)-propyl-(8-methyl-2,3-dihydro-1,4dioxino2,3-fquinolin-2-ylmethyl)-amine or a pharmaceutically acceptable salt thereof.
66. A compound according to claim 1, wherein said compound is 4-(6-fluoro-indol-1-yl)-butyl-methyl-(8-methyl-2,3-dihydro-1,4dioxino2,3-fquinolin-2-ylmethyl)-amine or a pharmaceutically acceptable salt thereof.
67. A compound according to claim 1, wherein said compound is 3-(4-fluoro-indol-1-yl)-propyl-methyl-(8-methyl-2,3-dihydro-1,4dioxino2,3-fquinolin-2-ylmethyl)-amine or a pharmaceutically acceptable salt thereof.
68. A compound according to claim 1, wherein said compound is N-4(5-Chloro-1-benzothien-3-yl)butyl-N-(2S)-8-methyl-2,3-dihydro1,4dioxino2,3-fquinolin-2-ylmethylamine or a pharmaceutically acceptable salt thereof.
69. A compound according to claim 1, wherein said compound is N-3-(5-Chloro-1-benzothien-3-yl)propyl-N-(2S)-8-methyl-2,3-dihydro1,4dioxino2,3-fquinolin-2-ylmethylamine or a pharmaceutically acceptable salt thereof.
70. A compound according to claim 1, wherein said compound is N-3-(5-Fluoro-1-benzothien-3-yl)propyl-N-(2S)-8-methyl-2,3-dihydro1,4dioxino2,3-fquinolin-2-ylmethylamine or a pharmaceutically acceptable salt thereof.
71. A compound according to claim 1, wherein said compound is N-4-(1-Benzofuran-3-yl)butyl-N-ethyl-N-(2S)-8-methyl-2,3-dihydro1,4dioxino2,3-fquinolin-2-ylmethylamine or a pharmaceutically acceptable salt thereof.
72. A compound according to claim 1, wherein said compound is the S enantiomer, substantially free of the R enantiomer of said compound.
73. A method of treating a subject suffering from a condition selected from depression, anxiety, panic disorder, post-traumatic stress disorder, premenstrual dysphoric disorder, attention deficit disorder, obsessive compulsive disorder, social anxiety disorder, generalized anxiety disorder, obesity, eating disorders, vasomotor flushing, cocaine and alcohol addiction, and sexual dysfunction, comprising the step of:
administering to said subject suffering from said condition, a therapeutically effective amount of a compound according to claim 1 or a pharmaceutically acceptable salt thereof.
74. A method according to claim 73, wherein the condition is depression.
75. A method according to claim 73, wherein the condition is selected from the group consisting of obsessive-compulsive disorder, panic attacks, generalized anxiety disorder, and social anxiety disorder.
76. A pharmaceutical composition, comprising:
an effective amount of a compound according to claim 1 or a pharmaceutically acceptable salt thereof; and
a pharmaceutically acceptable carrier or excipient.

1. A method for providing electronic options for goods or services, comprising:
transmitting from a server network device with one or more processors to a client network device with one or more processors via a computer network, a list of available goods or services including a plurality of electronic options with associated electronic option fees for the list of goods or services, wherein the plurality of electronic options include a plurality of different electronic option terms established by one or more suppliers who can supply the goods or services, wherein the plurality of electronic options are not supplied or governed via a central government agency and are not supplied or governed via security laws and wherein an electronic option fee is associated with a reservation price to purchase desired goods or services at a desired future time;
transmitting from the server network device a hierarchy of electronic options for a selected good or service for a desired supplier who can supply the selected good or service, wherein the hierarchy of electronic options includes selected ones of electronic options purchased for goods or services that do not currently exist and may never exist and other selected ones of electronic options purchased for a sporting event or entertainment event that may or may never happen, and vet other selected ones of the electronic options purchased for goods or services that do exist and sporting events or entertainment events that will happen;
accepting a purchase of an electronic option from the hierarchy of electronic options for an option fee for a desired good or service for a desired supplier at a desired reservation price on the server network device from the client network device via the communications network, wherein the purchase of the electronic option is accepted according to electronic option terms established by the desired supplier and wherein a final purchase price for a desired good or service is determined by a number of electronic options for the desired good or service purchased from the hierarchy of electronic options and may be different than a reservation price included in the electronic option;
determining on the server network device an interest in the goods or services with a number of purchases of electronic options from the hierarchy of electronic options, wherein the determined interest provides an economic feasibility of continuing to develop the desired good or service or is used to determine final pricing and final features for the desired good or service; and
receiving a request from a purchaser of an electronic option to exercise the electronic option on the server network device from the client network device via the computer network to purchase the desired good or service at a final purchase price, wherein the final purchase price of the desired good or service is directly determined by a number of electronic options purchased from the hierarchy of electronic options and wherein if a large number of electronic options have been purchased for the desired good or service, the final purchase price of the desired good or service will be greater than the reservation price included in the electronic option.
2. A non-transitory computer readable medium having stored therein a plurality of instructions for causing one or more processors on a network device to execute the steps of:
transmitting from a server network device with one or more processors to a client network device with one or more processors via a computer network, a list of available goods or services including a plurality of electronic options with associated electronic option fees for the list of goods or services, wherein the plurality of electronic options include a plurality of different electronic option terms established by one or more suppliers who can supply the goods or services, wherein the plurality of electronic options are not supplied or governed via a central government agency and are not supplied or governed via security laws-and wherein an electronic option fee is associated with a reservation price to purchase desired goods or services at a desired future time;
transmitting from the server network device a hierarchy of electronic options for a selected good or service for a desired supplier who can supply the selected good or service, wherein the hierarchy of electronic options includes selected ones of electronic options purchased for goods or services that do not currently exist and may never exist and other selected ones of electronic options purchased for a sporting event or entertainment event that may or may never happen, and vet other selected ones of the electronic options purchased for goods or services that do exist and sporting events or entertainment events that will happen;
accepting a purchase of an electronic option from the hierarchy of electronic options for an option fee for a desired good or service for a desired supplier at a desired reservation price on the server network device from the client network device via the communications network, wherein the purchase of the electronic option is accepted according to electronic option terms established by the desired supplier and wherein a final purchase price for a desired good or service is determined by a number of electronic options for the desired good or service purchased from the hierarchy of electronic options and may be different than a reservation price included in the electronic option;
determining on the server network device an interest in the goods or services with a number of purchases of electronic options from the hierarchy of electronic options, wherein the determined interest provides an economic feasibility of continuing to develop the desired good or service or is used to determine final pricing and final features for the desired good or service; and
receiving a request from a purchaser of an electronic option to exercise the electronic option on the server network device from the client network device via the computer network to purchase the desired good or service at a final purchase price, wherein the final purchase price of the desired good or service is directly determined by a number of electronic options purchased from the hierarchy of electronic options and wherein if a large number of electronic options have been purchased for the desired good or service, the final purchase price of the desired good or service will be greater than the reservation price included in the electronic option.
3. The method of claim 1 wherein the hierarchy includes electronic options for goods including tickets for sporting events or entertainment events.
4. The method of claim 1 wherein the hierarchy includes a hierarchy of electronic options for a plurality of different models for a desired good or service.
5. The method of claim 1 further comprising:
receiving terms for an electronic option in the hierarchy of electronic options for a selected good or service on the server network device via the computer network from the client network device;
calculating an electronic option fee based on the received electronic option terms; and
storing the received electronic option terms and calculated electronic option fee in a database associated with the server network device as an available electronic option.
6. The method of claim 5 further comprising:
determining a final purchase price for a desired good or service directly by a number of electronic options purchased from the hierarchy of electronic options; and
storing the final purchase price in the database associated with the server network device.
7. The method of claim 5 wherein the receiving step includes:
receiving terms for an electronic option that are desired by a consumer from the client network device via the communications network; and
accepting via a supplier the electronic option terms desired by the consumer, thereby creating a new available electronic option created by the consumer and accepted and supplied by a supplier who can supply the desired good or service.
8. The method of claim 7 further comprising:
offering an available electronic option with electronic option terms desired by the consumer and an electronic option fee calculated from the desired consumer to other consumers and thus allowing the consumer who proposed the electronic options terms to act as an electronic option broker.
9. The method of claim 8 further comprising:
recording information in the database to identify the consumer who is acting as the electronic option broker.
10. The method of claim 5 wherein the electronic option terms obligate an option holder to purchase the good or service at the time of expiration of the electronic option.
11. The method of claim 5 wherein the electronic option terms obligate an option holder to purchase the good or service upon first availability of the good or service.
12. The method of claim 5 wherein the electronic option terms include a conditional event that obligates an option holder to purchase the good or service upon successful completion of the conditional event.
13. The method of claim 5 wherein the electronic option terms include a conditional event that obligates the option holder to purchase the good or service upon at a specified date after successful completion of the conditional event.
14. The method of claim 5 wherein the electronic option terms include a conditional event that does not obligate the option holder to purchase the good or service upon at a specified date after successful completion of the conditional event.
15. The method of claim 5 wherein the calculating step includes calculating an electronic option fee with offer or counteroffer negotiation between a supplier and a consumer.
16. The method of claim 5 wherein the server network device is a dedicated electronic options exchange server.
17. The method of claim 16 wherein the dedicated electronic options exchange server charges a service fee to a buyer or seller or buyer and seller of an electronic option that is purchased via the dedicated electronic options exchange server.
18. The method of claim 5 wherein the received electronic option terms specify that if the goods or service does not become available by a pre-determined date or conditional event, a portion of the electronic option fee will be refunded.
19. The method of claim 5 wherein the received electronic option terms specify that if the goods or service does not become available by a pre-determined date or conditional event, a substitute good or service is made available that may be of greater, less than or equal value to the original product at a price that is greater, less than, or equal to the original exercise price of the option.
20. A system for providing electronic options for goods or services, comprising in combination:
means for receiving terms for an electronic option on a server network device with one or more processors via a computer network from a client network device with one or more processors;
means for calculating an electronic option fee on the server network device based on the received electronic option terms;
means for storing the received electronic option terms and the calculated electronic option fee are stored in a database associated with the server network device;
means for transmitting from the server network device to the client network device via the computer network, a list of available goods or services including a plurality of electronic options with associated electronic option fees for the list of goods or services, wherein the plurality of electronic options include a plurality of different electronic option terms established by one or more suppliers who can supply the goods or services, wherein the plurality of electronic options are not supplied or governed via a central government agency and are not supplied or governed via security laws-and wherein an electronic option fee is associated with a reservation price to purchase desired goods or services at a desired future time;
means for transmitting from the server network device a hierarchy of electronic options for a selected good or service for a desired supplier who can supply the selected good or service, wherein the hierarchy of electronic options includes selected ones of electronic options purchased for goods or services that do not currently exist and may never exist and other selected ones of electronic options purchased for a sporting event or entertainment event that may or may never happen, and yet other selected ones of the electronic options purchased for goods or services that do exist and sporting events or entertainment events that will happen;
means for accepting a purchase of an electronic option from the hierarchy of electronic options for an option fee for a desired good or service for a desired supplier at a desired reservation price on the server network device from the client network device via the communications network, wherein the purchase of the electronic option is accepted according to electronic option terms established by the desired supplier and wherein a final purchase price for a desired good or service is determined by a number of electronic options for the desired good or service purchased from the hierarchy of electronic options and may be different than a reservation price included in the electronic option;
means for determining on the server network device an interest in the goods or services with a number of purchases of electronic options from the hierarchy of electronic options, wherein the determined interest provides an economic feasibility of continuing to develop the desired good or service or is used to determine final pricing and final features for the desired good or service;
means for receiving a request from a purchaser of an electronic option to exercise the electronic option on the server network device from the client network device via the computer network to purchase the desired good or service at a final purchase price, wherein the final purchase price of the desired good or service is directly determined by a number of electronic options purchased from the hierarchy of electronic options and wherein if a large number of electronic options have been purchased for the desired good or service, the final purchase price of the desired good or service will be greater than the reservation price included in the electronic option;
means for receiving electronic option terms for an electronic option that is desired by a consumer from the client network device via the communications network on the server network device;
means for accepting via a supplier the electronic option terms desired by the consumer on the server network device, thereby creating a new available electronic option created by the consumer and accepted and supplied by a supplier who can supply the desired good or service; and
means for offering new available electronic options with electronic option terms desired by the consumer and an electronic option fee calculated from the accepted electronic option terms desired consumer to other consumers from the server network device and thus allowing the consumer who proposed the electronic options terms to act as an electronic option broker.
21. The method of claim 5 wherein a number electronic options purchased from the hierarchy of electronic options are used to determine an economic feasibility of continuing to develop the desired good or service or used to determine final features included in the desired good or service.
22. The method of claim 21 wherein the calculating step includes calculating the electronic option fee based on a winning bid of an auction to purchase an electronic option for the desired good or service.

The claims below are in addition to those above.
All refrences to claim(s) which appear below refer to the numbering after this setence.

1. A method for applying an adhesive to a finger surface of a substrate, comprising:
providing a contactless application device comprising at least 2 nozzles for ejecting adhesive onto the substrate without contacting the substrate,
providing a modified adhesive comprising
a condensation resin selected from the group of urea formaldehyde (UF) resin, melamine formaldehyde resin (MF), modified melamine formaldehyde resin (xMF) and phenol resorcinol formaldehyde resin (PRF) or combinations thereof,
optionally a hardener,

wherein the rheology of the adhesive is modified by at least one of the following measures:
cooling to a temperature between 5 and 15\xb0 C. to a viscosity of at least 5000 mPas,
including into the adhesive a viscosity increasing substance to increase the viscosity to at least 3000 mPas, and
including a thixotropic increasing substance in an effective amount to prevent sagging of the adhesive on the surface.
2. The method according to claim 1, wherein the hardener is applied separately to a substrate and wherein also the rheology of the hardener is modified by at least one of the following measures
cooling to a temperature between 5 and 15\xb0 C.,
including into the adhesive a viscosity increasing substance, and
including a thixotropic increasing substance in an effective amount to prevent sagging of the adhesive on the surface.
3. The method according to claim 1, wherein the rheology modified adhesive and hardener are applied separately and unmixed on the same surface or each to another opposing substrate surface to be adhered.
4. The method according to claim 1, wherein the condensation resin is urea formaldehyde resin comprising between 20% and 60% wt % urea, or wherein the condensation resin is a melamine formaldehyde resin comprising between 25% and 50% melamine or wherein the condensation resin is liquid melamine modified melamine formaldehyde resin comprising between 3% and 50% wt % melamine.
5. The method according to claim 1, wherein hardener and resin are mixed and the hardener to resin dosage is 5 to 50 wt % hardener to 100 wt % resin.
6. The method according to claim 1, wherein the hardener and the resin are applied separately and wherein the hardener to resin dosage is from 10 to 200 wt % hardener to 100 wt % resin.
7. The method according to claim 1, wherein the condensation resin is PRF resin comprising between 5% and 50% wt % resorcinol (calculated on total resin solids weight).
8. The method according to claim 7, wherein hardener and resin are mixed and the hardener to resin dosage is 10 to 50 wt % hardener to 100 wt % resin.
9. The method according to claim 1, wherein the viscosity andor thixotropy increasing substance is selected from the group of carboxymethyl cellulose, hydroxyethyl cellulose, cellulose fibers, polyvinyl alcohol, polyurethane thickener, polyurea sag control agent (SCA), polyvinyl pyrrolidone thickener, swellable emulsions, xanthan gum, fumed silica and clay.
10. The method according to claim 1, wherein the viscosity andor thixotropy increasing substance is present from 0.1 to 10 wt % calculated based on the total weight of at least one of the liquid resin and the hardener.
11. The method according to claim 1, wherein the substrate comprises at least one wood product, a laminated panel or a laminated beam.
12. The method according to claim 1, wherein the composition is applied to a substrate through cooled nozzles.
13. An apparatus for applying an adhesive composition in a contactless finger joint application, comprising a contactless finger joint applicator, which comprises cooled nozzles for applying and cooling an adhesive to 5-15\xb0 C., wherein the adhesive is a modified adhesive comprising: a condensation resin selected from the group of urea formaldehyde (UF) resin, melamine formaldehyde resin (MF), modified melamine formaldehyde resin (xMF) and phenol resorcinol formaldehyde resin (PRF) or combinations thereof, and wherein the adhesive further optionally comprises a hardener.
14. The apparatus according to claim 13, wherein the contactless finger joint applicator comprises at least 2 nozzles for ejecting the adhesive onto a substrate.
15. The apparatus according to claim 13, further comprising a temperature regulation mechanism.
16. The apparatus according to claim 13, wherein the adhesive rheology is further modified by at least one of the following measures:
including into the adhesive a viscosity increasing substance to increase the viscosity to at least 3,000 mPas, and
including a thixotropic increasing substance in an effective amount to prevent sagging of the adhesive on the surface.
17. The apparatus according to claim 13, wherein the adhesive is cooled to a temperature between 5 and 15\xb0 C. to a viscosity of at least 5000 mPas.